226
Participants
Start Date
June 14, 2017
Primary Completion Date
July 19, 2018
Study Completion Date
September 21, 2018
Nemolizumab
Injection every 4 weeks during 24 weeks (last injection at week 20)
Placebo
Injection every 4 weeks during 24 weeks (last injection at week 20)
Galderma Investigational site, New York
Galderma Investigational Site, New York
Galderma Investigational Site, Berlin
Galderma Investigational Site, Berlin
Galderma Investigational site, Forest Hills
Galderma Investigational Site, Marseille
Galderma Investigational Site, Hamburg
Galderma Investigational site, Richmond
Galderma Investigational site, Chapel Hill
Galderma Investigational site, Sandy Springs
Galderma Investigational Site, Hannover
Galderma Investigational Site, Toulouse
Galderma Investigational site, Columbus
Galderma Investigational Site, Bordeaux
Galderma Investigational site, Miami
Galderma Investigational site, Tampa
Galderma Investigational Site, Tampa
Galderma Investigational site, Birmingham
Galderma Investigational Site, Osnabrück
Galderma Investigational Site, Mainz
Galderma Investigational Site, Lille
Galderma Investigational Site, Darien
Galderma Investigational Site, Frankfurt
Galderma Investigational Site, Darmstadt
Galderma Investigational Site, Overland Park
Galderma Investigational Site, Heidelberg
Galderma Investigational site, New Orleans
Galderma Investigational Site, Stuttgart
Galderma Investigational site, Fort Smith
Galderma Investigational Site, Paris
Galderma Investigational site, Dallas
Galderma Investigational Site, Waco
Galderma Investigational site, San Antonio
Galderma Investigational Site, Farmington Hills
Galderma Investigational Site, München
Galderma Investigational Site, Langenau
Galderma Investigational site, Beverly Hills
Galderma Investigational site, Rolling Hills Estates
Galderma Investigational site, Santa Monica
Galderma Investigational Site, Erlangen
Galderma Investigational site, Santa Ana
Galderma Investigational site, Fountain Valley
Galderma Investigational site, Fremont
Galderma Investigational Site, Johnston
Galderma Investigational Site, Benowa
Galderma Investigational Site, Kogarah
Galderma Investigational Site, Melbourne
Galderma Investigational Site, Phillip
Galderma Investigational Site, Calgary
Galderma Investigational Site, Markham
Galderma Investigational Site, Oakville
Galderma Investigational Site, Ottawa
Galderma Investigational Site, Ottawa
Galderma Investigational Site, Peterborough
Galderma Investigational Site, Richmond Hill
Galderma Investigational Site, Sainte-Foy
Galderma Investigational Site, Waterloo
Galderma Investigational Site, Nice
Galderma Investigational Site, Katowice
Galderma Investigational Site, Katowice
Galderma Investigational Site, Krakow
Galderma Investigational Site, Lodz
Galderma Investigational Site, Lublin
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Wroclaw
Lead Sponsor
Galderma R&D
INDUSTRY